Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Glioblastoma × Platinum × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 14 Squamous Cell Carcinoma of Head and Neck 10 Small Cell Lung Carcinoma 9 Lung Neoplasms 8 Urinary Bladder Neoplasms 5 Oropharyngeal Neoplasms 5 Mouth Neoplasms 5 Laryngeal Neoplasms 5 Carcinoma 5 Uterine Cervical Neoplasms 4 Hypopharyngeal Neoplasms 4 Breast Neoplasms 4 Stomach Neoplasms 3 Nasopharyngeal Carcinoma 3 Adenocarcinoma of Lung 3 Vulvar Neoplasms 2 Triple Negative Breast Neoplasms 2 Salivary Gland Neoplasms 2 Recurrence 2 Paranasal Sinus Neoplasms 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Liver Neoplasms 2 Head and Neck Neoplasms 2 Fallopian Tube Neoplasms 2 Cholangiocarcinoma 2 Brain Neoplasms 2 Anus Neoplasms 2 Urethral Neoplasms 1 Ureteral Neoplasms 1

Interventions

Temozolomide 140 Bevacizumab 80 Radiotherapy 69 Magnetic Resonance Spectroscopy 22 Radiation 18 Irinotecan 18 pembrolizumab 17 Lomustine 16 Carmustine 15 Surgical Procedures, Operative 13 Nivolumab 11 Erlotinib Hydrochloride 11 sargramostim 9 Thalidomide 9 Specimen Handling 9 Chemotherapy, Adjuvant 9 Aminolevulinic Acid 9 Carboplatin 8 Cilengitide 7 Sunitinib 6 Immunoglobulin G 6 Etoposide 6 Disulfides 6 Cyclophosphamide 6 antineoplaston AS 2-1 5 antineoplaston A10 5 Radiotherapy, Intensity-Modulated 5 Radiosurgery 5 Metformin 5 Imatinib Mesylate 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07138001 2025-08-22

Phase 2 Clinical Trial of KH617

Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Phase 2 Not yet recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡